Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 5
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Value Stock, Under Radar

332.9000 -15.60 (-4.48%)

NSE Apr 04, 2025 15:31 PM

New 52W Low today

Volume: 286.1K

Aarti Drugs Ltd.

30 Oct 2022

332.90

-4.48%

Result Update:Aarti Drugs

Buy: Aarti Drugs Ltd.

Recommendation Target

Axis Direct

Aarti Drugs could be benefitted in upcoming quarters, we upgrade to BUY on Aarti Drugs with Target Price of Rs 545

Aarti Drugs Ltd. has lost -35.53% in the last 6 Months